Total budget impact (no case detection–case detection) results
Outcome | S1a | S1b | S1c | S2a | S3a | S3b | S3c | S3d |
---|---|---|---|---|---|---|---|---|
No case detection strategy costs (million $) | ||||||||
Case detection: physician time* | 0 | |||||||
Case detection: use cost* | 0 | |||||||
Treatment | 2300 | |||||||
Hospital admission | 4786 | |||||||
Outpatient† | 7666 | |||||||
Total | 14 752 | |||||||
Case detection strategy costs (million $) | ||||||||
Case detection: physician time* | 107 | 107 | 107 | 69 | 44 | 44 | 44 | 44 |
Case detection: use cost* | 293 | 228 | 314 | 155 | 89 | 139 | 99 | 132 |
Treatment | 2365 | 2325 | 2312 | 2329 | 2306 | 2337 | 2321 | 2314 |
Hospital admission | 4772 | 4779 | 4780 | 4779 | 4781 | 4777 | 4779 | 4780 |
Outpatient† | 7637 | 7649 | 7652 | 7648 | 7660 | 7649 | 7654 | 7657 |
Total | 15 175 | 15 087 | 15 165 | 14 980 | 14 880 | 14 947 | 14 898 | 14 927 |
Budget impact (million $)‡ | ||||||||
Case detection: physician time* | −107 | −107 | −107 | −69 | −44 | −44 | −44 | −44 |
Case detection: use cost* | −293 | −228 | −314 | −155 | −89 | −139 | −99 | −132 |
Treatment | −65 | −25 | −12 | −29 | −6 | −37 | −21 | −14 |
Hospitalization | 13 | 7 | 6 | 7 | 5 | 9 | 7 | 6 |
Outpatient† | 29 | 17 | 14 | 18 | 7 | 17 | 12 | 9 |
Total | −423 | −335 | −412 | −228 | −128 | −195 | −146 | −175 |
Note: S1a = CDQ ≥ 17 points for all patients, S1b = flow metre (with bronchodilator) all patients, S1c = CDQ ≥ 17 points + flow metre (with bronchodilator) all patients, S2a = flow metre (without bronchodilator) among symptomatic patients, S3a = CDQ ≥ 19.5 points among patients aged ≥ 50 yr with a smoking history, S3b = CDQ ≥ 16.5 points among patients aged ≥ 50 yr with a smoking history, S3c = flow metre (without bronchodilator) among patients aged ≥ 50 years with a smoking history, S3d = CDQ ≥ 17 points + flow metre (with bronchodilator) among patients aged ≥ 50 yr with a smoking history.
Results based on a single run of EPIC per scenario.
↵* Case detection costs have been split by time (time-related cost of physician implementing case detection) and use cost (cost of flow meter technology and outpatient spirometry diagnosis).
↵† Outpatient care are the remaining costs not included in case detection, treatment or hospital admission and includes COPD maintenance costs, routine diagnosis, and costs associated with mild and moderate exacerbations which are assumed not to result in hospital admission.
↵‡ Negative budget impact indicates budget expansion.